Trump Demands Drug Companies Slash US Prices in Blow to Industry

In a move to address high drug prices in the United States, President Donald Trump has sent letters to 17 of the world's largest pharmaceutical companies, demanding they lower the prices of new medicines in the US to match the prices charged in other countries. The President's actions represent an escalation of his ongoing campaign to pressure the drug industry to reduce costs for American consumers. Trump has criticized the industry for charging significantly higher prices in the US compared to other nations, and this latest move is seen as an attempt to force the companies to align their US pricing with international standards. The pharmaceutical industry has faced growing scrutiny over its pricing practices, with concerns that high drug costs are making crucial medications unaffordable for many Americans. Trump's demand for price reductions is viewed as a direct challenge to the industry's business model and could have significant implications for the future of drug pricing in the United States.